Director/PDMR Shareholding

Arix Bioscience Plc

04 May 2023

 

Arix Bioscience plc
("Company")

PDMR notifications & Director Shareholdings

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

The Company has been notified that Robert Lyne, Chief executive Officer, has sold a total of 107,657 Ordinary shares of 0.001 pence each in the Company ("Shares") on 04 May 2023 at an average price of 105 pence per share and bought on 04 May 2023, into his ISAs and SIPP, a total of 107,657 Shares at an average price of 107 pence per share.

The notification below, made in accordance with the requirements of UK Market Abuse Regulation, provides further detail on the respective transactions.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Robert Lyne
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Arix Bioscience plc Ordinary shares of 0.001 pence each
	Identification code	GB00BD045071
b)	Nature of the transaction	Share Disposal
c)	Price(s) and volume(s)		Price(s)£	Volume(s)
			1.)      £1.052 2.)       £1.053 3.)       £1.0526 4.)       £1.0425	22,238 20,000 8,419 57,000
d)	Aggregated information
	- Aggregated volume	107,657
	- Price (£)	£112,669.14
e)	Date of the transaction	4 May 2023
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Robert Lyne
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Arix Bioscience plc Ordinary shares of 0.001 pence each
	Identification code	GB00BD045071
b)	Nature of the transaction	Share Purchase
c)	Price(s) and volume(s)		Price(s)(£)	Volume(s)
			£1.069 £1.069 £1.068	57,014 8,419 42,224
d)	Aggregated information
	- Aggregated volume	107,657
	- Price (£)	£115,094.42
e)	Date of the transaction	4 May 2023
f)	Place of the transaction	London Stock Exchange

Ends.

For further information please contact:
Kin Company Secretarial Limited, Company Secretary
[phone]

 

END